首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: The AWARE randomized clinical trial
【24h】

Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: The AWARE randomized clinical trial

机译:风险减少咨询对快速艾滋病毒检测的影响对性传播感染的风险:Acap Accound临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

IMPORTANCE: To increase human immunodeficiency virus (HIV) testing rates, many institutions and jurisdictions have revised policies to make the testing process rapid, simple, and routine. A major issue for testing scale-up efforts is the effectiveness of HIV risk-reduction counseling, which has historically been an integral part of the HIV testing process. OBJECTIVE: To assess the effect of brief patient-centered risk-reduction counseling at the time of a rapid HIV test on the subsequent acquisition of sexually transmitted infections (STIs). DESIGN, SETTING, AND PARTICIPANTS: From April to December 2010, Project AWARE randomized 5012 patients from 9 sexually transmitted disease (STD) clinics in the United States to receive either brief patient-centered HIV risk-reduction counseling with a rapid HIV test or the rapid HIV test with information only. Participants were assessed for multiple STIs at both baseline and 6-month follow-up. INTERVENTIONS: Participants randomized to counseling received individual patient-centered risk-reduction counseling based on an evidence-based model. The core elements included a focus on the patient's specific HIV/STI risk behavior and negotiation of realistic and achievable risk-reduction steps. All participants received a rapid HIV test. MAIN OUTCOMES AND MEASURES: The prespecified outcome was a composite end point of cumulative incidence of any of the measured STIs over 6 months. All participants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema pallidum (syphilis), herpes simplex virus 2, and HIV. Women were also tested for Trichomonas vaginalis. RESULTS: There was no significant difference in 6-month composite STI incidence by study group (adjusted risk ratio, 1.12; 95% CI, 0.94-1.33). There were 250 of 2039 incident cases (12.3%) in the counseling group and 226 of 2032 (11.1%) in the information-only group. CONCLUSION AND RELEVANCE: Risk-reduction counseling in conjunction with a rapid HIV test did not significantly affect STI acquisition among STD clinic patients, suggesting no added benefit from brief patient-centered risk-reduction counseling. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01154296.
机译:重要性:为了增加人类免疫缺陷病毒(艾滋病毒)测试率,许多机构和司法管辖区都有修改的政策,使测试过程快速,简单和常规。测试扩大努力的主要问题是艾滋病毒风险减少咨询的有效性,这在历史上一直是艾滋病毒检测过程的组成部分。目的:评估在随后收购性传播感染的快速艾滋病毒试验时,评估简短的患者居中风险咨询的影响(STIS)。设计,设定和参与者:从4月到2010年12月,项目意识到来自美国的9例性传播疾病(STD)诊所的随机5012名患者,以获得简短的患者为中心的艾滋病毒风险减少咨询,并具有快速的HIV测试或仅使用信息快速艾滋病毒检测。在基线和6个月的随访中评估了参与者的多个STI。干预:参与者随机咨询基于证据的模型获得了基于证据的个人患者以患者为中心的风险减少咨询。核心元素包括对患者的特异性艾滋病毒/ STI风险行为和谈判的重点是现实和可实现的风险减少步骤。所有参与者都获得了快速的HIV测试。主要结果和措施:预先发现的结果是6个月内任何测量的STI的累积发病率的复合终点。所有参与者都测试了Neisseria Gonorrhoeae,Chlamydia Trachomatis,Treponema Pallidum(梅毒),单纯疱疹病毒2和HIV。妇女也被测试为滴虫游戏术。结果:研究组6个月复合STI发病率没有显着差异(调整风险比,1.12; 95%CI,0.94-1.33)。咨询组中有250例(12.3%),咨询集团,226名(12.3%)在仅限信息集团中。结论和相关性:与快速艾滋病毒检测结合风险减少咨询在STD诊所患者中没有显着影响STI习得,表明没有额外的益处从简短的患者为中心的风险减少咨询。试验登记ClinicalTrials.gov标识符:NCT01154296。

著录项

  • 来源
  • 作者单位

    Department of Sociomedical Sciences Mailman School of Public Health Columbia University 722 W;

    Department of Public Health Sciences Miller School of Medicine University of Miami Miami FL;

    Department of Sociomedical Sciences Mailman School of Public Health Columbia University 722 W;

    Department of Public Health Weill Cornell Medical College New York NY United States;

    HIV Prevention Section San Francisco Department of Public Health San Francisco CA United States;

    HIV Prevention Section San Francisco Department of Public Health San Francisco CA United States;

    Center for AIDS and STD University of Washington Seattle WA United States Public Health;

    HIV Prevention Section San Francisco Department of Public Health San Francisco CA United States;

    Department of Psychiatry and Behavioral Science Medical University of South Carolina Charleston;

    HIV Center for Clinical and Behavioral Studies Department of Psychiatry Columbia University New;

    Department of Health Science California State University Long Beach CA United States;

    University of Pittsburgh School of Medicine Pittsburgh PA United States;

    Department of Medicine Oregon Health and Science University Portland OR United States;

    Division of Infectious Diseases Department of Medicine University of South Carolina School of;

    Elizabeth Taylor Medical Center Whitman-Walker Health Washington DC United States;

    Jeffrey Goodman Special Care Clinic Los Angeles Gay and Lesbian Center Los Angeles CA United;

    STD Prevention and Control San Francisco Department of Public Health San Francisco CA United;

    Department of Medicine Miller School of Medicine University of Miami Miami FL United States;

    Department of Sociomedical Sciences Mailman School of Public Health Columbia University 722 W;

    Duval County Health Department Jacksonville FL United States;

    National Institute on Drug Abuse National Institutes of Health Bethesda MD United States;

    Division of HIV/AIDS Prevention National Center for HIV Hepatitis STD and TB Prevention;

    HIV Prevention Section San Francisco Department of Public Health San Francisco CA United States;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

  • 入库时间 2022-08-19 19:21:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号